Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
136.44
-0.21 (-0.15%)
At close: Mar 28, 2025, 4:00 PM
136.84
+0.40 (0.29%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Cardinal Health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Cardinal Health stock have an average target of 136.36, with a low estimate of 120 and a high estimate of 150. The average target predicts a decrease of -0.06% from the current stock price of 136.44.
Analyst Consensus: Buy
* Price targets were last updated on Feb 5, 2025.
Analyst Ratings
The average analyst rating for Cardinal Health stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 4 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 5 | 5 | 6 | 5 | 5 | 5 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $140 → $150 | Hold → Strong Buy | Upgrades | $140 → $150 | +9.94% | Feb 5, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $142 → $145 | Hold | Maintains | $142 → $145 | +6.27% | Feb 4, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $135 → $136 | Hold | Maintains | $135 → $136 | -0.32% | Feb 4, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $136 → $142 | Buy | Maintains | $136 → $142 | +4.08% | Jan 31, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $127 → $135 | Hold | Maintains | $127 → $135 | -1.06% | Jan 29, 2025 |
Financial Forecast
Revenue This Year
225.27B
from 226.83B
Decreased by -0.68%
Revenue Next Year
244.81B
from 225.27B
Increased by 8.67%
EPS This Year
8.03
from 3.45
Increased by 132.85%
EPS Next Year
9.06
from 8.03
Increased by 12.73%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 236.0B | 264.6B | 285.6B | ||
| Avg | 225.3B | 244.8B | 262.7B | ||
| Low | 215.5B | 231.6B | 243.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.0% | 17.4% | 16.7% | ||
| Avg | -0.7% | 8.7% | 7.3% | ||
| Low | -5.0% | 2.8% | -0.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.44 | 9.63 | 10.83 | ||
| Avg | 8.03 | 9.06 | 10.00 | ||
| Low | 7.75 | 8.57 | 9.46 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 144.7% | 19.9% | 19.5% | ||
| Avg | 132.8% | 12.7% | 10.5% | ||
| Low | 124.7% | 6.6% | 4.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.